Bio-Techne Sells Exosome Diagnostics to Mdxhealth to Strengthen Precision Diagnostics Bio-Techne has finalized a deal to sell its Exosome Diagnostics business to Mdxhealth, enhancing their focus on innovative precision diagnostics.

Bio-Techne Sells Exosome Diagnostics to Mdxhealth to Strengthen Precision Diagnostics #USA #Minneapolis #Bio-Techne #Exosome_Diagnostics #Mdxhealth

MDxHealth Awarded College of American Pathologists (CAP) ... MDxHealth, a developer of epigenetic tests for cancer, ha...

#MDxHealth Awarded College of American Pathologists (CAP) Accreditation www.businesswire.com/news/home/20120731005805... via @BusinessWire